The global transdermal patch market, projected to grow from $1.61 billion in 2024 to $2.35 billion by 2029, is expected to reach $18 billion by 2030, expanding at a CAGR of 7.8%. The U.S. leads with a ...
MUMBAI: Zydus Lifesciences Limited received the final nod from the United States Food and Drug Administration (USFDA) to market its Scopolamine Transdermal System, delivering 1 mg of the medication ...
Lifetimes of Achievement honorees Peter Carpenter, right, and Jane Shaw Carpenter, right, in Palo Alto on Feb. 6, 2023. Photo by Magali Gauthier. Peter Carpenter and Jane Shaw Carpenter have made ...
NEW DELHI, Sept. 10, 2020 /PRNewswire/ -- "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: Download Report: https ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/1b304d/the_top_50_transde) has announced the addition of the "The Top 50 ...
SAN ANTONIO — Sept. 6, 2022 — Southwest Research Institute has developed an efficient, fully synthetic method to produce scopolamine, a plant-derived compound used to prevent nausea and vomiting from ...
The approval granted by the US Food and Drug Administration (USFDA) is to market the Scopolamine transdermal system of dosage 1 mg/3 days, Zydus Lifesciences said in a regulatory filing. New Delhi: ...
(MENAFN- GlobeNewsWire - Nasdaq) The global transdermal patch market, projected to grow from $1.61 billion in 2024 to $2.35 billion by 2029, is expected to reach $18 billion by 2030, expanding at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback